SCHEMBL30833130

SCHEMBL30833130

CC(C)(C)OC(=O)N1CCC(c2cc(F)cnc2C(=O)NN)CC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
GPR119 Q8TDV5 3/20 0.45
TP53 P04637 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
ALOX5AP P20292 1/20 0.44
FEN1 P39748 1/20 0.44
DPP4 P27487 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833127 1.00 ALDH1A1 (0.47) ALDH1A1LMNACYP3A4CYP2D6CYP2C9
SCHEMBL30833105 0.87 ALDH1A1 (0.47) ALDH1A1LMNACYP3A4CYP2D6CYP2C9
SCHEMBL30833107 0.86 LMNA (0.43) ALDH1A1LMNACYP3A4CYP2D6CYP2C9
SCHEMBL24330056 0.77 HSD11B1 (0.56) GPR119SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL1464028 0.77 KDM4E (0.48) GPR119TP53SMN1; SMN2KDM4EMAPT
SCHEMBL23842631 0.76 GPR119 (0.57) GPR119TP53SMN1; SMN2KDM4EMAPT
SCHEMBL12210723 0.76 THRB (0.49) GPR119TP53SMN1; SMN2KDM4EMAPT
SCHEMBL21245878 0.75 ALOX5AP (0.52) GPR119SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL31046259 0.74 KIT (0.46) GPR119SMN1; SMN2MAPT
SCHEMBL29334908 0.74 KIT (0.46) GPR119SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587432-A1 M4 ACTIVATORS/MODULATORS AND USES THEREOF Cerevel Therapeutics, LLC (US) 2025-07-23 EP disclosed
WO-2024059249-A1 M4 ACTIVATORS/MODULATORS AND USES THEREOF CEREVEL THERAPEUTICS, LLC (US) 2024-03-21 WO disclosed